Consequently, data collection might be minimal, perhaps only evaluating parameters such as expression of the transgene/dystrophin and the North Star Ambulatory Assessment (NSAA), a 17-items measurement tool commonly used in DMD trials (55).10 Here, DMD is linked to Duchenne muscular dystrophy.